Press Releases March 30, 2026 08:00 PM

AirSculpt Technologies Announces Fourth Quarter and Fiscal Year 2025 Earnings Release Date and Conference Call

AirSculpt Technologies to release Q4 and FY2025 earnings with a follow-up conference call

By Leila Farooq
Share
Twitter Reddit Facebook LinkedIn
AIRS

AirSculpt Technologies, leader in premium body contouring procedures, announced its forthcoming Q4 and full fiscal year 2025 earnings release scheduled before market open on April 2, 2026, followed by a conference call and webcast for investors.

AirSculpt Technologies Announces Fourth Quarter and Fiscal Year 2025 Earnings Release Date and Conference Call
AIRS
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Earnings for Q4 and full fiscal year 2025 will be reported on April 2, 2026, before market open.
  • A conference call and live webcast will provide insights and Q&A opportunities for investors immediately after the earnings release.
  • AirSculpt offers minimally invasive body contouring treatments that emphasize comfort and precision, impacting the cosmetic and healthcare sectors.

MIAMI BEACH, Fla., March 31, 2026 (GLOBE NEWSWIRE) -- AirSculpt Technologies, Inc. (“AirSculpt”) (NASDAQ: AIRS) an industry leader and provider of premium body contouring procedures, today announced it will report fourth quarter and fiscal year 2025 financial results before market open on Thursday, April 2, 2026, to be followed by a conference call on the same day at 8:30 a.m. Eastern Time.

The conference call can be accessed by dialing 1-877-407-9716 (toll-free domestic) or 1-201-493-6779 (international) using the conference ID 13758597 or by clicking this link to request a return call for instant telephone access to the event. The live webcast may be accessed via the investor relations section of the AirSculpt Technologies website at https://investors.airsculpt.com. A replay of the webcast will be available for approximately 90 days.

About AirSculpt

AirSculpt is a next-generation body contouring treatment designed to optimize both comfort and precision, available exclusively at AirSculpt offices. The minimally invasive procedure removes fat and tightens skin, while sculpting targeted areas of the body, allowing for quick healing with minimal bruising, tighter skin, and precise results.

Investor Contact:

Allison Malkin
Partner, ICR Inc.
AirSculpt@icrinc.com


Risks

  • Financial results may fall short of market expectations, impacting stock price negatively in the healthcare and consumer discretionary sectors.
  • Market reception of the earnings call could be muted if no significant operational updates or growth guidance is provided.
  • Any regulatory or operational challenges related to medical procedures could affect company performance and investor sentiment.

More from Press Releases

GoHealth, Inc. to strengthen its position ahead of AEP 2026 through Restructuring Process supported by key stakeholders Jun 7, 2026 Real-World Evidence of Eversense 365 Presented at ADA Demonstrating Strong Performance and Patient Impact in Both Open and Closed Loop Systems Jun 6, 2026 All In FutureTech Alliance Provides Strategic Updates: Hainan AIFA Digital Industrial Park, Silicon Photonics Compute Center Planning, and Cross-Border Optical Network Integration Jun 6, 2026 Cullinan Therapeutics Presents Initial Clinical Data for CLN-978, a CD19xCD3 T Cell Engager, at the EULAR 2026 Congress Jun 6, 2026 InterPrivate Investment Partners V, Inc. Announces Closing of $201.25 Million Initial Public Offering Jun 5, 2026